Vaccines for the prevention of neglected diseases — dengue fever

This publication has 29 references indexed in Scilit:

• PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
  The American Journal of Tropical Medicine and Hygiene, 2003
• The future of dengue vaccines
  The Lancet, 2002
• Dengue: an escalating problem
  BMJ, 2002
• Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam.
  Vaccine, 2002
• Break-bone fever
  Nature, 2002
• Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
  The American Journal of Tropical Medicine and Hygiene, 2002
• Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century
  Trends in Microbiology, 2002
• Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections
  Vaccine, 2002
• Dengue: an update
  The Lancet Infectious Diseases, 2002
• Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
  Vaccine, 2001